texte alternatif                                    

    List of publications of Eric Trepo


      Contributions to collective works (1)
  1. 1. Moreno, C., & Trepo, E. (2013). Vitamin D deficiency and liver disease. In V. Arroyo & J. Rodés (Eds.), Advances in therapy of liver diseases. Spain: Ars Medica.
    2.   Peer-reviewed journal articles (82)
  2. 1. Arab, J. P., Díaz, L. A., Rehm, J., Im, G. Y., Arrese, M., Kamath, P. S., Lucey, M. R., Mellinger, J., Thiele, M., Thursz, M. M., Bataller, R., Burton, R., Chokshi, S., Francque, S., Krag, A., Lackner, C., Lee, B. B., Liangpunsakul, S., MacClain, C., Mandrekar, P., Mitchell, M. M., Morgan, M. Y., Morgan, T. R., Pose, E., Shah, V. H., Shawcross, D., Sheron, N., Singal, A. K., Stefanescu, H., Terrault, N., Trepo, E., Moreno, C., Louvet, A., & Mathurin, P. (2025). Metabolic dysfunction and alcohol-related liver disease (MetALD): Position statement by an expert panel on alcohol-related liver disease. Journal of hepatology. doi:10.1016/j.jhep.2024.11.028
  3. 2. Ningarhari, M., Lassailly, G., Dharancy, S., Moreno, C., & Trepo, E. (2025). Recurrence of Hepatocellular Carcinoma After Liver Transplantation: The Blind Spot of HCC Management. United European gastroenterology journal. doi:10.1002/ueg2.70078
  4. 3. Shen, T.-K., Vignane, T., Gilglioni, E. H., Traini, L., Kalaitsidou, E., Conan, P. L., Li, A., St-Pierre-Wijckmans, W., Herranz, J. M., Elvira Jimenez, B., Otero Sanchez, L., Trepo, E., Deelman, L., Wu, W., Filipovic, M. R., Messens, J., Ezeriņa, D., & Gurzov, E. N. (2025). Metabolic dysfunction-associated steatohepatitis reduces hepatic H2S-producing enzymes altering persulfidome composition. Redox Biology, 86, 103809. doi:10.1016/j.redox.2025.103809
  5. 4. Galvanin, C., Buch, S., Nahon, P., & Trepo, E. (2025). PNPLA3 in Alcohol-Related Liver Disease. Liver international, 45(1), e16211. doi:10.1111/liv.16211
  6. 5. Chang, C. W., Chen, Y. S., Huang, C. H., Lin, C. H., Ng, W. V., Chu, L. J., Trepo, E., Zucman-Rossi, J., Siao, K., Maher, J. J., Chiew, M. Y., Chou, C. H., Huang, H. D., Teo, W. H., Lee, S. I., Lo, J. F., & Wang, X. W. (2025). A genetic basis of mitochondrial DNAJA3 in nonalcoholic steatohepatitis-related hepatocellular carcinoma. Hepatology (Baltimore, Md.), 81(1), 60-76. doi:10.1097/HEP.0000000000000637
  7. 6. Hadefi, A., Leprovost, M., Dinsart, G., Marefati, M., Vermeersch, M., Monteyne, D., Perez-Morga, D., Lefort, A., Libert, F., Verset, L., Liefferinckx, C., Moreno, C., Devière, J., Trepo, E., & Garcia, M.-I. (2025). Duodenal Organoids From Metabolic Dysfunction-Associated Steatohepatitis Patients Exhibit Absorptive and Barrier Alterations. Gastro Hep Advances, 4(4), 100599. doi:10.1016/j.gastha.2024.100599
  8. 7. Nault, J. C., Sritharan, N., Verset, G., Borbath, I., Lequoy, M., Allaire, M., Regnault, H., Colle, I., Orlent, H., Sinapi, I., Moreno, C., Larrey, E., Sidali, S., Hollande, C., Amaddeo, G., Pol, S., Nahon, P., Ganne-Carrié, N., Levy, V., Bloch-Queyrat, C., Trepo, E., & Bouattour, M. (2024). Patient and physician expectations regarding disease and treatment of advanced HCC: The prospective PERCEPTION1 study. JHEP Reports, 6(11), 101192. doi:10.1016/j.jhepr.2024.101192
  9. 8. Gilglioni, E. H., Li, A., St-Pierre-Wijckmans, W., Shen, T.-K., Perez Chavez, I., Hovhannisyan, G. G., Lisjak, M., Negueruela Escudero, J., Vandenbempt, V., Bauzá-Martinez, J., Herranz, J. M., Ezeriņa, D., Demine, S., Feng, Z., Vignane, T., Otero Sanchez, L., Lambertucci, F., Prašnická, A., Devière, J., Hay, D. C., Encinar, J. A., Singh, S. P., Messens, J., Filipovic, M. R., Sharpe, H. J., Trepo, E., Wu, W., & Gurzov, E. N. (2024). PTPRK regulates glycolysis and de novo lipogenesis to promote hepatocyte metabolic reprogramming in obesity. Nature communications, 15(1), 9522. doi:10.1038/s41467-024-53733-0
  10. 9. Zeng, Q., Klein, C., Caruso, S., Maille, P., Allende, D. S., Mínguez, B., Iavarone, M., Ningarhari, M., Casadei-Gardini, A., Pedica, F., Rimini, M., Perbellini, R., Boulagnon-Rombi, C., Heurgué, A., Maggioni, M., Trepo, E., Vij, M., Baulande, S., Legoix, P., Lameiras, S., HCC-AI study group,, Bruges, L., Gnemmi, V., Nault, J. C., Campani, C., Rhee, H., Park, Y. N., Iñarrairaegui, M., Garcia-Porrero, G., Argemi, J., Sangro, B., D'Alessio, A., Scheiner, B., Pinato, D. J., Pinter, M., Paradis, V., Beaufrère, A., Peter, S., Rimassa, L., Di Tommaso, L., Vogel, A., Michalak, S., Boursier, J., Loménie, N., Ziol, M., & Calderaro, J. (2023). Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study. Lancet oncology, 24(12), 1411-1422. doi:10.1016/S1470-2045(23)00468-0
  11. 10. Marot, A., Henrion, J., Knebel, J. F., Trepo, E., Moreno, C., & Deltenre, P. (2023). A model for individualized prediction of liver-related death in outpatients with alcohol-associated cirrhosis. Hepatology Communications, 7(9). doi:10.1097/HC9.0000000000000229
  12. 11. Hadefi, A., Arvanitakis, M., Trepo, E., & Zelber-Sagi, S. (2023). Dietary strategies in non-alcoholic fatty liver disease patients: From evidence to daily clinical practice, a systematic review. United European gastroenterology journal, 11(7), 663-689. doi:10.1002/ueg2.12443
    13. << Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 Next >>